Home › Focal Segmental Glomerulosclerosis › California › Los Angeles
Focal Segmental Glomerulosclerosis clinical trials in Los Angeles, CA
6 studies for Focal Segmental Glomerulosclerosis are looking for participants at sites in and around Los Angeles (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 2
- Investigator Site #14, Los Angeles
A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
RecruitingPhase 3
- Academic Medical Research Institute - Glendale, Los Angeles
- Kaiser Permanente - Los Angeles Medical Center, Los Angeles
- University of California Los Angeles, Los Angeles
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
Recruiting
- Cedars Sinai Medical Center, Los Angeles
Nephrotic Syndrome Study Network
RecruitingObservational study
- University of Southern California-Children's Hospital, Los Angeles
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
RecruitingPhase 2
- Cedars-Sinai Medical Center, Los Angeles
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
RecruitingPhase 3
- Cedars-Sinai Medical Center, Los Angeles
- University of California, Los Angeles, Los Angeles
Focal Segmental Glomerulosclerosis trials in other cities
- Philadelphia, PA9 studies
- Durham, NC8 studies
- New York City, NY7 studies
- Ann Arbor, MI6 studies
- Miami, FL6 studies
- Queens, NY6 studies
- Atlanta, GA5 studies
- Houston, TX5 studies
- Cleveland, OH4 studies
- Chicago, IL4 studies
- Dallas, TX4 studies
- Kansas City, MO4 studies
Other studies in Los Angeles
- Non-Small Cell Lung Cancer87 studies
- Cancer (all types)73 studies
- Breast Cancer72 studies
- Prostate Cancer61 studies
- Colorectal Cancer59 studies
- Metastatic Cancer57 studies
- Ovarian Cancer50 studies
- Lung Cancer45 studies
- Head and Neck Squamous Cell Carcinoma42 studies
- Pancreatic Cancer35 studies
- Endometrial Cancer34 studies
- Melanoma34 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.